Clinical Trial Update: Evaluation of Thoracic Tumors With 18F-FMT and 18F-FDG PET-CT A Clinicopathological Study

View source ↗

Summary

This completed clinicopathological study evaluates thoracic tumors in non-small cell lung cancer using PET-CT imaging with 18F-FMT and 18F-FDG.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• 18F-FDG (fluorodeoxyglucose F-18)
• 18F-FMT (fluoromethyl tyrosine radiotracer)

Snippet

Sponsor: Gunma University | Conditions: Non-Small Cell Lung Cancer | Status: COMPLETED